Inventing a novel topical application called-DVolve SilverSoothe ScarCream- A Revolutionary Formulation for Scar Reduction and Wound Healing

This is a prospective study done to evaluate the efficacy and safety of the cream in 30 first degree burn patients in Saveetha Medcial college and hospital. Patients with first-degree burns confirmed by medical assessment. Age 18 years and above. Willing to participate in the study and provide informed consent. Available for follow-up assessments as required. Able to understand and comply with study procedures are included in the study. Patients with burns other than first-degree (e.g., second-degree, third-degree burns).Age below 18 years. Inability to provide informed consent (e.g., cognitive impairment), Presence of pre-existing conditions that may affect burn healing (e.g., diabetes, immunocompromised status), Pregnancy, as hormonal changes may impact burn healing, Unwillingness or inability to comply with study procedures or follow-up assessments are excluded from the study. Patient surveys or questionnaires administered to gather subjective feedback on pain levels, scar appearance, and overall satisfaction with the cream’s effectiveness. Objective measurements such as scar dimensions, tissue elasticity, and wound healing rates obtained through clinical assessments conducted by trained healthcare professionals Laboratory analyses of biological samples (e.g., skin biopsies) to evaluate histological changes, cytokine levels, and other biomarkers associated with wound healing and scar formation. Documentation of adverse events, medication adherence, and other relevant clinical data obtained from patient medical records and follow-up appointments.